Department of Indian System of Medicine Jammu has refuted the news published in a local daily titled 14 ISM drugs found toxic with high quantity of Pb, Hg, AS.
In a communiqué issued by Deputy Director ISM, it is informed that the department follows all the norms and procedures prescribed by the government in every purchase of medicines. Every medicine purchase is being done in view of provisions of Drug and Cosmetic Act 1940 and rules amended there under i.e good manufacturing practices, licensing, labeling etc from licensing authorities /drug controller of the concerned states where these medicines are being manufactured.
Besides, quality and authenticity of the Ayurvedic medicines is checked on the basis of standards of identity, purity and strength prescribed in the Pharmacopoeia. For this purpose, Central government has setup pharmacopoeia laboratory of Indian medicines in Ghaziabad, Uttar Pradesh as an appellate Laboratory.
After purchase, every medicine is received with batch wise analytic report from NABL Laboratory. Moreover, there is a provision that if any medicine is found substandard, department takes action according to law i.e blacklisting the firm and/or exchange the medicines.